Home » Topics » Cancer, BioWorld Science

Cancer, BioWorld Science
RSS

New cannabinoid CB1 and CB2 receptor ligands identified at Canopy Growth Corp.

Feb. 4, 2021

DexTech expands preclinical program to evaluate OsteoDex in multiple myeloma

Feb. 3, 2021

Curis initiates phase II LUCAS study of CA-4948 as treatment for anemia in MDS

Feb. 3, 2021

Phase I data presented for AXL inhibitor DS-1205c plus osimertinib in EGFR-mutated NSCLC

Feb. 3, 2021

Annamycin shows significant therapeutic benefit in metastatic osteosarcoma animal model

Feb. 3, 2021

WCLC 2021: KRAS drugs may do best in tough subtype

Feb. 2, 2021

Updated results presented from TRIDENT-1 study of repotrectinib

Feb. 2, 2021

Mobocertinib shows clinical benefit in patients with exon 20-mutated NSCLC

Feb. 2, 2021

Sun Pharma Advanced Research describes new camptothecin derivative prodrugs

Feb. 2, 2021

Allinky Biopharma presents GTPase KRas inhibitors

Feb. 1, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 25, 2026.
Have brain-computer interfaces finally arrived?
BioWorld
More and more individuals now have chronically implanted brain-computer interface (BCI) systems in their heads. Devices that can record and stimulate neural...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 23, 2026
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...
2026 marks critical turning point for BCI technology
BioWorld
Decades of research are helping unravel the “black box” of the brain. The second article in BioWorld’s series on the Brain-Computer Interface (BCI) field looks at...